Wednesday, 14 October 2020

Autosamplers Market Analysis During COVID-19 Pandemic

 Advantages of autosamplers over manual injection systems, growing importance of chromatography in drug approvals, and increasing production of crude and shale oil are some of the key factors driving the growth of the market.

According to the new market research report by MarketsandMarkets, the global Autosamplers Market is projected to reach $1,136.2 Million by 2022 from $730.2 Million in 2016, at a CAGR of 7.6%.

Autosamplers Market by Product (Systems (Liquid Chromatography, GC (Liquid, Headspace, All-in-one)), Accessories (Syringe & Needle, Vial, Septum) & Enduser (Pharmaceutical companies, Oil & Gas, Food & Beverage, Environment testing).

Download PDF Brochurehttps://www.marketsandmarkets.com/pdfdownloadNew.asp?id=156038985

This report broadly segments the autosamplers market into product and end user. On the basis of product, the market is categorized into autosampler systems and autosampler accessories. The autosampler systems segment is further segmented into liquid chromatography (LC) autosampler and Gas Chromatography (GC) autosampler, while autosampler accessories are further segmented into vials, syringes, needles, and septum. GC autosampler systems are further segmented into three types–liquid, headspace, and all in one.

In 2017, the autosamplers systems segment is expected to account for the largest share. Largest share of this segment is mainly attributed to LC autosamplers systems being adopted rapidly in various industries like pharmaceutical and food & beverages.

Based on end user, the autosamplers market is segmented into pharmaceutical and biopharmaceutical industry, oil and gas industry, food and bevarage industry, Environmental Testing industry, and other end user segment. The pharmaceutical and biopharmaceutical segment is estimated to command the largest share of the global autosamplers market in 2017. Growing importance of chromatography tests in the drug approval process and increasing funds for R&D activities in pharmaceutical and biopharmaceutical industries are key factors driving the growth of the market.

Request for Sample Pages:

The report covers the autosamplers market across four major regions, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is expected to command the largest share of the market in 2017 due to the increasing funds for R&D activities in healthcare industries, growing funding for environmental testing and cleanup activities in the US, government initiatives to improve laboratory infrastructure, and government investments for environmental protection in Canada.

Key Players : https://www.marketsandmarkets.com/requestsampleNew.asp?id=156038985

The major players of the autosamplers market are Agilent (US), Waters (US), Shimadzu (Japan), Thermo Fisher (US), and PerkinElmer (US). The other players in this market include Merck (Germany), Bio-Rad (US), Restek (US), Gilson (US), JASCO (US), and SCION (US).

Tuesday, 13 October 2020

Medical Device Reprocessing Market worth USD 1,754 Million by 2022

 The medical device reprocessing includes cleaning, disinfection, inspection, sterilization, and repackaging of used medical devices for its reuse to diagnose and treat multiple patients.

The growth of this market is majorly driven by the increased utilization of the low priced reprocessed medical devices as compared to new devices, increased efforts towards reducing regulated medical waste (RMW), and rising number of surgical procedures associated with the growing prevalence of chronic diseases. However, the risk of transmission of surgical site infections associated with the use of reprocessed devices may hinder the growth of the market to a certain extent.


According to the new market research report by MarketsandMarkets, the global medical device reprocessing market is projected to reach USD 1,754.0 Million by 2022 from USD 823.5 Million in 2017, at a CAGR of 16.3%.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=583

The report analyzes the market by product & service, type of medical device, application, and region. On the basis of product & service, the reprocessing support and services segment accounted for the largest share in 2016, owing to the increased adoption of third-party reprocessing services over in-house reprocessing services by hospitals, clinics, surgical centers, clinical pathologies, and other healthcare organizations.

Based on type of medical device, the catheters segment accounted for the largest share in 2016 and is expected to grow at the highest CAGR during the forecast period. The growth of this segment can be attributed to the increased utilization of reprocessed cardiac catheters, electrophysiology catheters, and diagnostic catheters in recent years.

Based on application, the market is further categorized into cardiology; gastroenterology, urology, and gynecology; arthroscopy and orthopedic surgery; and general surgery and anesthesia.

North America accounted for the largest share of the Medical Device Reprocessing Market

Geographically, the global medical device reprocessing market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. In 2016, North America dominated the market, and this is primarily attributed to its well-established healthcare industry, growing prevalence of chronic diseases, and increasing volume of surgical procedures. The European region is expected to witness the highest CAGR during the forecast period, owing to the rising prevalence of chronic diseases, increasing geriatric population, rising healthcare expenditure, increasing number of surgical procedures, and growing awareness about the usage of reprocessed medical devices.

Request for Sample Pageshttps://www.marketsandmarkets.com/requestsampleNew.asp?id=583

Maior Key Players Mapped in Research Report:

In 2016, Stryker Corporation (U.S.) and Johnson & Johnson (U.S.) dominated the global medical device reprocessing market. Some of the other players competing in this market are Vanguard AG (Germany), Medline ReNewal (U.S.), Medtronic plc (Ireland), SteriPro Canada, Inc. (Canada), Pioneer Medical Devices AG (Germany), Vascular Solutions, Inc. (U.S.), HYGIA Health Services, Inc. (U.S.), ReNu Medical, Inc. (U.S.), SureTek Medical (U.S.), and Centurion Medical Products Corporation (U.S.).

Friday, 9 October 2020

Western Blotting Market Worth 7307 Million USD by 2021 : CAGR of 4.9%

  The growth of the overall market can be attributed to the increasing number of research activities and R&D spending by pharmaceutical and biotechnology companies, rising prevalence of HIV/AIDS, and growing proteomics market are key factors driving the demand for western blotting instruments and consumables, increasing demand for personalized medicine, and new product launches are some of the other factors driving the growth of this market.

What the Market Looks Like? 

The western blotting market is projected to reach USD 730.7 Million by 2021 from USD 574.8 Million in 2016, at a CAGR of 4.9% in the next five years (2016 to 2021). North America is expected to account for the largest share of the global market. 

In the coming years, the market is expected to witness the highest growth in the Asia-Pacific region. This can be attributed to increasing government interest in biomedical & biotechnology industry in China, government initiatives supported by funding in Japan, growing funding for agriculture research in India, increasing diagnosis and related funding in Australia, and growing prevalence of herpes simplex virus (HSV) in southeast Asia.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=235810711

What Drives the Market?

The growth of the  Western Blotting Market is primarily influenced by the following factors:

  • Increasing Research Activities and R&D Spending By Pharmaceutical and Biotechnology Companies
  • Rising Prevalence of HIV/Aids
  • Growing Proteomics Market
  • Growing Number of Industry-Academic Research Collaborations
  • Increasing Demand for Personalized Medicine
  • New Product Launches

Increasing number of research activities and R&D spending by pharmaceutical and biotechnology companies, rising prevalence of HIV/AIDS, growing proteomics market, growing number of industry-academic research collaborations, increasing demand for personalized medicine, and new product launches are expected to drive the growth of the market in the coming years.

Read more about Western Blotting Market

@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=235810711

Thursday, 8 October 2020

Health Information Exchange Market : Need to Curtail Healthcare Costs'

 Federal mandates like Meaningful use, growing patient-centric approach in healthcare delivery, increasing EHR adoption rate, and need to curtail healthcare cost are some of the key factors driving the growth of market.

What the Market Looks Like? 
 
[201 Pages Report] The health information exchange market is projected to reach USD 1,545.0 million by 2020 from USD 990.6 million in 2015, at a CAGR of 9.3% during the forecast period. The health information exchange market in Asia-Pacific is expected to grow at the fastest rate during the forecast period. 

Health information exchange (HIE) involves the electronic movement of health-related information among organizations according to nationally recognized standards. HIE aims to facilitate the access and retrieval of clinical data to provide safer, timelier, efficient, effective, equitable, patient -centered care. 

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=249987292

What Drives the Market?

The growth of the Health Information Exchange Market is primarily influenced by the following factors:

  •  Strong Government Support and Initiatives
  • Increased Measures to Improve Healthcare Quality and Care Coordination Likely to Trigger HIE Adoption
  • Need to Curtail Healthcare Costs

The growing awareness among consumers regarding air purification in the wake of COVID-19 is an opportunity for air purifier retailers to scale up their sales. Some companies are increasing the production of air quality systems with the addition of different technologies such as High-Efficiency Particulate Air (HEPA) filters, photocatalytic purifiers, activated carbon purifiers, and ionic filters.

Read more about Health Information Exchange Market
@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=249987292

Tuesday, 6 October 2020

Laboratory Freezers Market is projected to reach USD 3.76 Billion by 2021, at a CAGR of 4.6%

 The increasing demand for blood & blood components, rising government support for research activities and clinical trials, and technological advancements in freezers & refrigerators are the major factors driving the growth of the market. Untapped emerging regions are expected to offer new growth opportunities for players operating in this market in the coming years.

According to the new market research report by MarketsandMarketsthe global Laboratory Freezers market is projected to reach USD 3.76 Billion by 2021, at a CAGR of 4.6% from 2016 to 2021. 

Laboratory Freezers Market by Product (Cryopreservation, Plasma Freezer, Explosion-Proof Freezer, Enzyme Freezer, Ultra-Low Freezer, Blood Bank Refrigerator, Pharmacy Refrigerator, Chromatography Refrigerator) & by End User – Global Forecast to 2021

Download PDF Brochurehttps://www.marketsandmarkets.com/pdfdownloadNew.asp?id=196600540


laboratory freezers market is segmented by product type, end user, and region. This research report discusses the key market drivers, restraints, opportunities, and challenges in the global market and its submarkets. Based on product type, the market is segmented into freezers, refrigerators, and cryopreservation systems. The freezers segment accounted for the largest share of the market in 2015, and is expected to grow at a significant CAGR during the forecast period. Technological advancements in freezers and increasing use of plasma freezers as a result of the growing demand for plasma from biopharmaceutical companies are driving the growth of this market segment.

Laboratory Freezers Market is segmented into freezers, refrigerators, and cryopreservation systems. The freezers segment accounted for the largest share of the market in 2015, and is expected to grow at a significant CAGR during the forecast period. Technological advancements in freezers and increasing use of plasma freezers as a result of the growing demand for plasma from biopharmaceutical companies are driving the growth of this market segment.

Based on end user, the laboratory freezers market is segmented into hospitals, medical laboratories, pharmacies, academic & research institutes, blood banks, and pharmaceutical & biotechnology companies. The blood banks segment accounted for the largest share of the market in 2015. The large share of this segment can be attributed to the rising demand for whole blood and blood components, owing to the increasing prevalence of blood disorders such as sickle cell anemia, blood cancer, and hemophilia.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=196600540

Geographical Growth Analysis:

Global laboratory freezers market is studied at regional and country levels. In 2015, North America represented the largest regional market, followed by Europe. Although North America will continue to dominate the global market during the forecast period, the Asia-Pacific region is expected to register the highest market growth in the coming years. A majority of the growth in this region is driven by the improving healthcare infrastructure, increasing investments by government agencies, growth in biotechnology research, and rising focus of key market players on emerging Asia-Pacific countries.

Some key players mentioned in the research report are:

The key players in this market are Thermo Fisher Scientific Inc. (U.S.), Haier Biomedical (China), Eppendorf AG (Germany), Helmer Scientific (U.S.), VWR Corporation (U.S.), ARCTIKO A/S (Europe), Biomedical Solutions Inc. (U.S.), EVERmed S.R.L. (Italy), Philipp Kirsch GmbH (Germany), and Panasonic Healthcare Co., Ltd. (Japan).

Monday, 5 October 2020

Global Veterinary Care Market is expected to reach $9 billion by 2025

 The veterinary care market is expected to foresee positive trends throughout the forecast period. Substantial market growth can be attributed to the rising initiatives undertaken by the regulatory authorities. Government authorities collaborate with veterinarians and develop schemes that assure the availability of optimum inventory at fields for treating the farm animals.

An increase in demand for animal health products showcases growth trends for the veterinary care market. There has been a considerable demand for animal health products in Asian countries, and the animal health market is predicted to grow at 5.2% during the forecast period.

According to the new market research report by MarketsandMarkets, the global Latin America animal health market size is projected to reach around USD 9 billion by 2025 from around USD 5.2 billion in 2018, at a CAGR of 7.3% during the forecast period.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=78396315


Global Veterinary Care Market is Segmented on:

The animal type segment of the veterinary care market is bifurcated further into dogs, cats, pigs, poultry, cattle, and horses. Livestock animals such as cattle and poultry are expected to experience higher medicalization rates during the forecast years. In emerging economies such as the Philippines and Vietnam, earlier, poultry health was neglected, and owners used to discard the chickens in bulk during a virus outbreak. Similar was the condition of a few cattle farms. Unorganized farms were often neglected, and that hampered the overall meat production in such countries. However, the current laws have been framed to scrutinize the situation in farms and ensure maximum animal protection.

Based on the type of treatment, the veterinary care market is segmented into no medicalization, basic medicalization, and under veterinary care. The percentage of non-medicalized animals is going to experience a decline over the next few years. The major reason behind this sharp decrease in no medicalization in animals is rising awareness amongst the farm as well as the pet owners. Moreover, government initiatives to promote animal welfare has also raised the medicalization rate in animals; thus, proving beneficial for the overall market.

Geographical Growth Analysis:

Latin America is one of the regions that has experienced significant growth in animal health space for the past few years. Countries such as Brazil and Argentina have shown potential demand for veterinary products and services. Several major players in the veterinary space have considered expansion Latin America due to the enormous growth opportunities it offers in the animal health industry.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=78396315

Some key players mentioned in the research report are:

The leading players in the animal treatment market include Zoetis (US), Merck (US), Boehringer Ingelheim (Germany), Elanco (US), Ceva (France), Phibro Animal Health Corporation (US), Virbac SA (France), IDEXX Laboratories, Inc., Neogen Corporation (US), Heska Corporation (US) and others. These players undertake several strategic initiatives such as mergers, acquisitions, new product launches, and geographical expansions that helps them in sustaining market competition.

Thursday, 1 October 2020

Gas Chromatography Market Development of policies and initiatives to reduce environmental pollution levels

 The growth in this market is driven by the increasing adoption of GC-MS, rising crude & shale oil production, increasing importance of wastewater treatment, rising food safety concerns, and growing use of chromatography tests in the drug approval process

What the Market Looks Like?  
  
[166 Pages Report] The global GC market size is projected to reach USD 3.5 billion by 2025 from USD 2.8 billion in 2020, at a CAGR of 4.1%. The market in North America is projected to witness the highest growth rate during the forecast period (2020–2025).


However, the high cost of GC equipment, geopolitical issues prevailing in some countries, and shortage of skilled professionals are expected to restrain the growth of this market during the forecast period. The systems segment of the GC instruments market is expected to account for the highest growth due to factors such increased capability to analyze complex compounds.

Download PDF Brochure @ www.marketsandmarkets.com/pdfdownloadNew.asp?id=101656773

What Drives the Market?
The growth of the GC market is primarily influenced by the following factors:

  • Increasing crude & shale oil production
  • Collaborations between chromatography instrument manufacturers and research laboratories/academic institutes
  • Rising adoption of GC-MS
  •  Development of policies and initiatives to reduce environmental pollution levels 
  • Growing food safety concerns 
  • Growing importance of chromatography tests in the drug approval process

On the basis of accessories and consumables, the GC market is divided into columns, columns accessories, autosampler accessories, flow management accessories, consumables & accessories, fittings & tubing, pressure regulators, gas generators, and other accessories. The columns segment is estimated to account for the largest share in the global gas chromatography market. The large share of this segment can primarily be attributed to factors such as improved gas chromatography columns for the petroleum industry.

Read more about GC market @ www.marketsandmarkets.com/requestsampleNew.asp?id=101656773